Immunic (IMUX) Reports New Data From Phase 2 EMPhASIS Trial

Immunic (IMUX) Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium

Immunic (IMUX) Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , New York , United States , Hohendorf , Sachsen , Hella Kohlhof , Lawrence Steinman , Steinmanl Epstein Barr , Heinz Wiendl , Larry Steinman , Fred Lublin , Daniel Vitt , Andreas Muehler , Fredd Lublin , Institute Of Translational Neurology , Department Of Neurology , University Of Mu , Stanford University School Of Medicine , Neurological Sciences , Nasdaq , Department Of Neurology Neurological Sciences , Icahn School Of Medicine , Corinne Goldsmith Dickinson Center , Immunic Inc , Confirmed Disability Worsening , Chief Executive Officer , Multiple Sclerosis Rd Webcast , Saunders Family Professor , Multiple Sclerosis , Icahn School , Mount Sinai Hospital , Stanford University School , Director Department , Translational Neurology , Chief Medical , Chief Scientific , Chief Medical Officer ,